Melinda Lackey

CIK: 0001898184

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

VBIO

Valion Bio, Inc.

Officer

TCRT

Alaunos Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

VBIO
Valion Bio, Inc.
May 1, 2026
Award(A)
Employee Stock Option (Right to Purchase)
Direct
45K shares-
TCRT
Alaunos Therapeutics, Inc.
Mar 29, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
1K shares-

		Type	Shares	Price		Ownership
May 1, 2026	VBIO Valion Bio, Inc.	Award(A) Employee Stock Option (Right to Purchase)	45,000	-	-	Direct
Mar 29, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	1,000	-	-	Direct

1-2 of 2 transactions

About Lackey Melinda

Lackey Melinda (SEC CIK 0001898184) files insider reports with the SEC as General Counsel & SVP of Legal of Valion Bio, Inc. (VBIO) and Legal & Administration of Alaunos Therapeutics, Inc. (TCRT).

Signal8 holds 3 ownership filings by Lackey Melinda (1 Form 3, 2 Form 4), filed between Apr 1, 2025 and May 4, 2026. Those filings report 2 transactions, from Mar 29, 2025 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lackey Melinda's filings is in SAN ANTONIO, TX.

Recent filings by Lackey Melinda

May 1, 2026: Grant or award of VBIO derivative securities (Form 4, code A).
Mar 29, 2025: Grant or award of TCRT derivative securities (Form 4, code A).

Other insiders filing for Valion Bio, Inc. (VBIO)

Zikria Dean, Interim CEO
Wolf Lisa G, COO & CFO
Malbin Jared David, Director
Jensen Thomas, Director

How to read Form 4 transaction codes